Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial
Heparin and enoxaparin possess anti-inflammatory properties. We compared the effects of these drugs on inflammatory biomarkers in patients with ST-segment Elevated Myocardial Infarction (STEMI).
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Shaheed Beheshti University of Medical Sciences
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157034/ |